Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.

M. C. Mauri, V. Laini, M. E. Scalvini, L. S. Volonteri, M. S. Ferrari, G. Panza

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

From many decades efficacy of lithium salts, as mood stabilizers, has been largely recognized, but their tolerability, in particular during intermediate or long-term treatments is still discussed. The most frequently described side effects can affect several organs. Aim of the study was to evaluate lithium carbonate tolerability after a "brief" (1 month-4 years), "intermediate" (5-9 years) and "longterm" (10-21 years) treatment of patients affected by Bipolar Disorders (BD). 27 patients (14 males, 13 females), aged from 20 to 78 years (mean 49.03 years +/- 14.61 SD), affected by BD, type I, according to DSM IV criteria were included into the study. Our data suggest a good tolerability of lithium salts without significant differences among the three different periods of treatment.

Original languageEnglish
Title of host publicationEuropean review for medical and pharmacological sciences
Pages63-69
Number of pages7
Volume3
Edition2
Publication statusPublished - Mar 1999

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.'. Together they form a unique fingerprint.

Cite this